[1] | Alfaraj, S. H., Al-Tawfiq, J. A., & Memish, Z. A. (2019). Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature. Journal of Microbiology, Immunology And Infection, 52(3), 501-503. https://doi.org/10.1016/j.jmii.2018.04.005. |
[2] | Anisoglou, S., Asteriou, C., Barbetakis, N., Kakolyris, S., Anastasiadou, G., & Pnevmatikos, I. (2013). Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure. Hippokratia, 17(1), 60-63. |
[3] | Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez De Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., … Lane, H. C. (2020). Remdesivir for the treatment of Covid-19 — preliminary report. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2007764. |
[4] | Bernheim, A., Mei, X., Huang, M., Yang, Y., Fayad, Z. A., Zhang, N., Diao, K., Lin, B., Zhu, X., Li, K., Li, S., Shan, H., Jacobi, A., & Chung, M. (2020). Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology, 295(3), 200463. https://doi.org/10.1148/radiol.2020200463. |
[5] | Bhaskar, S., Sinha, A., Banach, M., Mittoo, S., Weissert, R., Kass, J. S., Rajagopal, S., Pai, A. R., & Kutty, S. (2020). Cytokine Storm in COVID-19 — Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Frontiers In Immunology, 11. https://doi.org/10.3389/fimmu.2020.01648. |
[6] | Bhattacharya, M., Sharma, A. R., Patra, P., Ghosh, P., Sharma, G., Patra, B. C., Lee, S. S., & Chakraborty, C. (2020). Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. Journal of Medical Virology, 92(6), 618-631. https://doi.org/10.1002/jmv.25736. |
[7] | Bruce, E. A., Tighe, S., Hoffman, J. J., Laaguiby, P., Gerrard, D. L., Diehl, S. A., Leonard, D. G., Huston, C. D., Kirkpatrick, B. D., & Crothers, J. W. (2020). RT-qPCR Detection of SARS-CoV-2 RNA from Patient Nasopharyngeal Swab Using Qiagen RNEasy Kits or Directly via Omission of an RNA Extraction Step. BioRxiv. |
[8] | Bustin, S. A., & Nolan, T. (2020). RT-qPCR Testing of SARS-CoV-2: A Primer. International Journal Of Molecular Sciences, 21(8), 3004. https://doi.org/10.3390/ijms21083004. |
[9] | Cai, J., Sun, W., Huang, J., Gamber, M., Wu, J., & He, G. (2020). Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020. Emerging Infectious Diseases, 26(6), 1343-1345. https://doi.org/10.3201/eid2606.200412. |
[10] | Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z., Su, Y., Ma, Z., Zhang, Y., Li, Z., He, Q., Liu, L., Fu, Y., & Chen, J. (2020). COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy, 75(7), 1742-1752. https://doi.org/10.1111/all.14309. |
[11] | Chen, J., Qi, T., Liu, L., Ling, Y., Qian, Z., Li, T., Li, F., Xu, Q., Zhang, Y., Xu, S., Song, Z., Zeng, Y., Shen, Y., Shi, Y., Zhu, T., & Lu, H. (2020). Clinical progression of patients with COVID-19 in Shanghai, China. Journal Of Infection, 80(5), e1-e6. https://doi.org/10.1016/j.jinf.2020.03.004. |
[12] | Chrzanowski, W., Kim, S. Y., & McClements, L. (2020). Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections. Frontiers in Bioengineering and Biotechnology, 8, 554. |
[13] | CSG. (2020). The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 5(4), 536. |
[14] | Cui, J., Li, F., & Shi, Z. L. (2019). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 17(3), 181-192. https://doi.org/10.1038/s41579-018-0118-9. |
[15] | Davis, J. S., Ferreira, D., Denholm, J. T., & Tong, S. Y. (2020). Clinical trials for the prevention and treatment of coronavirus disease 2019 (COVID-19): The current state of play. The Medical Journal of Australia, 1. |
[16] | De Wit, E., Van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology, 14(8), 523. https://doi.org/10.1038/nrmicro.2016.81. |
[17] | Devaux, C. A., Rolain, J. M., Colson, P., & Raoult, D. (2020). New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?. International Journal Of Antimicrobial Agents, 55(5), 105938. https://doi.org/10.1016/j.ijantimicag.2020.105938. |
[18] | Elengoe, A. (2020). COVID-19 Outbreak in Malaysia. Osong public health and research perspectives, 11(3), 93. |
[19] | Engelman, D. T., Lother, S., George, I., Funk, D. J., Ailawadi, G., Atluri, P., Grant, M. C., Haft, J. W., Hassan, A., Legare, J. F., Whitman, G. J., & Arora, R. C. (2020). Adult cardiac surgery and the COVID-19 pandemic: Aggressive infection mitigation strategies are necessary in the operating room and surgical recovery. The Journal Of Thoracic And Cardiovascular Surgery, 160(2), 447-451. https://doi.org/10.1016/j.jtcvs.2020.04.059. |
[20] | Esquivel, D., Mishra, R., Soni, P., Seetharaman, R., Mahmood, A., & Srivastava, A. (2020). Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients. Stem cell reviews and reports, 1-9. https://doi.org/10.1007/s12015-020-10017-6. |
[21] | Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020). COVID-19: immunology and treatment options. Clinical Immunology, 215, 108448. https://doi.org/10.1016/j.clim.2020.108448. |
[22] | Gavriatopoulou, M., Korompoki, E., Fotiou, D., Ntanasis-Stathopoulos, I., Psaltopoulou, T., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2020). Organ-specific manifestations of COVID-19 infection. Clinical and Experimental Medicine, 1-14. https://doi.org/10.1007/s10238-020-00648-x. |
[23] | Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J. C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020). Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circulation research, 126(10), 1456-1474. https://doi.org/10.1161/CIRCRESAHA.120.317015. |
[24] | Golchin, A., Seyedjafari, E., & Ardeshirylajimi, A. (2020). Mesenchymal stem cell therapy for COVID-19: present or future. Stem cell reviews and reports, 1-7. |
[25] | Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J., Liu, L., Shan, H., Lei, C., Hui, D. S., Du, B., Li, L., Zeng, G., Yuen, K., Chen, R., Tang, C., Wang, T., Chen, P., Xiang, J., … Zhong, N. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18), 1708-1720. https://doi.org/10.1056/nejmoa2002032. |
[26] | Guo, Y. R., Cao, Q. D., Hong, Z. S., Tan, Y. Y., Chen, S. D., Jin, H. J., Tan, K. S., Wang, D. Y., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research, 7(1), 1-10. https://doi.org/10.1186/s40779-020-00240-0. |
[27] | Hasan, M. R., Mirza, F., Al-Hail, H., Sundararaju, S., Xaba, T., Iqbal, M., Alhussain, H., Yassine, H. M., Lopez, A. P., & Tang, P. (2020). Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA. PLOS ONE, 15(7), e0236564. https://doi.org/10.1371/journal.pone.0236564. |
[28] | Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N. H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271-280. e8. https://doi.org/10.1016/j.cell.2020.02.052. |
[29] | Iannaccone, G., Scacciavillani, R., Del Buono, M. G., Camilli, M., Ronco, C., Lavie, C. J., Abbate, A., Crea, F., Massetti, M., & Aspromonte, N. (2020). Weathering the Cytokine Storm in COVID-19: Therapeutic Implications. Cardiorenal medicine, 1-11. https://doi.org/10.1159/000509483. |
[30] | Johnson, B. S., & Laloraya, M. (2020). A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization. Cytokine & Growth Factor Reviews, S1359-6101 (1320) 30116-30117. |
[31] | Kang, L., Li, Y., Hu, S., Chen, M., Yang, C., Yang, B. X., Wang, Y., Hu, J., Lai, J., Ma, X., Chen, J., Guan, L., Wang, G., Ma, H., & Liu, Z. (2020). The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. The Lancet Psychiatry, 7(3), e14. https://doi.org/10.1016/s2215-0366(20)30047-x. |
[32] | Kudo, E., Israelow, B., Vogels, C., Lu, P., Wyllie, A. L., Tokuyama, M., Venkataraman, A., Brackney, D. E., Ott, I., Petrone, M., Earnest, R., Lapidus, S., Muenker, M. C., Moore, A. J., Casanovas-Massana, A., Omer, S. B., Cruz, C. S. D., Farhadian, S. F., Ko, A. I., … Grubaugh, N. D. (2020). Detection of SARS-CoV-2 RNA by multiplex RT-qPCR. BioRxiv. https://doi.org/10.1101/2020.06.16.155887. |
[33] | Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International Journal Of Antimicrobial Agents, 55(3) 105924. https://doi.org/10.1016/j.ijantimicag.2020.105924. |
[34] | Law, P. K. (2020). COVID-19 Pandemic: Its Origin, Implications and Treatments. Open Journal Of Regenerative Medicine, 9(02), 43. |
[35] | Lin, L., & Li, T. (2020). Interpretation of "guidelines for the diagnosis and treatment of novel coronavirus (2019-ncov) infection by the national health commission (trial version 5)". Zhonghua Yi Xue Za Zhi, 100, E001-E001. |
[36] | Lin, L., Lu, L., Cao, W., & Li, T. (2020). Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia. Emerging Microbes & Infections, 9(1), 727-732. |
[37] | Lizbeth, R., Jazmín, G., José, C., & Marlet, M. (2020). Immunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccine. Journal Of Biomolecular Structure and Dynamics, 1-15. https://doi.org/10.1080/07391102.2020.1780944. |
[38] | Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., … Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395(10224), 565-574. https://doi.org/10.1016/s0140-6736(20)30251-8. |
[39] | Marini, J. J., & Gattinoni, L. (2020). Management of COVID-19 respiratory distress. The Journal of the American Medical Association. |
[40] | Meng, Z., Wang, T., Li, C., Chen, X., Li, L., Qin, X., Li, H., & Luo, J. (2020). An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area. medRxiv. |
[41] | Möhlenkamp, S., & Thiele, H. (2020). Ventilation of COVID-19 patients in intensive care units. Beatmung von COVID-19-Patienten auf Intensivstationen. Herz, 45(4), 329–331. https://doi.org/10.1007/s00059-020-04923-1. |
[42] | Moll, G., Drzeniek, N., Kamhieh-Milz, J., Geissler, S., Volk, H. D., & Reinke, P. (2020). MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy. Frontiers in Immunology, 11, 1091. https://doi.org/10.3389/fimmu.2020.01091. |
[43] | Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao, Y., Hou, C., Wang, H., Liu, J., Yang, D., Xu, Yu., Cao, Z., & Gao, Z. (2020). Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care, 24(1), 1-10. https://doi.org/10.1186/s13054-020-03120-0. |
[44] | Nile, S. H., Nile, A., Qiu, J., Li, L., Jia, X., & Kai, G. (2020). COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine & Growth Factor Reviews. |
[45] | Olalla, J. (2020). Remdesivir for the Treatment of Covid-19-Preliminary Report. The New England Journal Of Medicine, 383. |
[46] | Orleans, L., Vice, H., & Manchikanti, L. (2020). Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use. Pain Physician, 23, E71-E83. |
[47] | Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., Yang, L., & Zhang, C. (2020). Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology, 295(3), 715-721. https://doi.org/10.1148/radiol.2020200370. |
[48] | Pooladanda, V., Thatikonda, S., & Godugu, C. (2020). The current understanding and potential therapeutic options to combat COVID-19. Life Sciences, 117765. |
[49] | Rabaan, A. A., Al-Ahmed, S. H., Haque, S., Sah, R., Tiwari, R., Malik, Y. S., Dhama, K., Yatoo, M. I., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020). SARS-CoV-2, SARS-CoV, and MERS-CoV: a comparative overview. Infez Med, 28(2), 174-184. |
[50] | Rajarshi, K., Chatterjee, A., & Ray, S. (2020). Combating COVID-19 with Mesenchymal Stem Cell therapy. Biotechnology Reports, e00467. |
[51] | Raoult, D., Zumla, A., Locatelli, F., Ippolito, G., & Kroemer, G. (2020). Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress, 4(4), 66. |
[52] | Rogers, C. J., Harman, R. J., Bunnell, B. A., Schreiber, M. A., Xiang, C., Wang, F.-S., Santidrian, A. F., & Minev, B. R. (2020). Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. Journal of Translational Medicine, 18, 1-19. |
[53] | Sabino-Silva, R., Jardim, A. C. G., & Siqueira, W. L. (2020). Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clinical Oral Investigations, 24(4), 1619-1621. |
[54] | Sallard, E., Halloy, J., Casane, D., Decroly, E., & van Helden, J. (2020). Tracing the origins of SARS-COV-2 in coronavirus phylogenies. Médecine/Sciences, 36(8-9). |
[55] | Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. The Journal of the American Medical Association, 323(18), 1824-1836. |
[56] | She, J., Jiang, J., Ye, L., Hu, L., Bai, C., & Song, Y. (2020). 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clinical and Translational Medicine, 9(1), 1-7. |
[57] | Shen, K., Yang, Y., Wang, T., Zhao, D., Jiang, Y., Jin, R., Zheng, Y., Xu, B., Xie, Z., Lin, L., Shang, Y., Lu, X., Shu, S., Bai, Y., Deng, J., Lu, M., Ye, L., Wang, X., Wang, Y., & Gao, L. (2020). Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World Journal of Pediatrics, 1-9. |
[58] | Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004). Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proceedings of the National Academy of Sciences, 101(12), 4240-4245. |
[59] | Singh, A. K., Majumdar, S., Singh, R., & Misra, A. (2020). Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. |
[60] | Singhal, T. (2020). A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics, 1-6. |
[61] | Smyrlaki, I., Ekman, M., Vondracek, M., Papanicoloau, N., Lentini, A., Aarum, J., Muradrasoli, S., Albert, J., Högberg, B., & Reinius, B. (2020). Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-qPCR. medRxiv. |
[62] | Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology, 24(6), 490-502. |
[63] | Ulrich, H., & Pillat, M. M. (2020). CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Reviews and Reports, 1-7. |
[64] | Velavan, T. P., & Meyer, C. G. (2020). The COVID‐19 epidemic. Tropical Medicine & International Health, 25(3), 278. |
[65] | Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G., Fu, H., Dighe, A., Griffin, J. T., Baguelin, M., Bhatia, S., Boonyasiri, A., Cori, A., Cucunubá, Z., FitzJohn, R., Gaythorpe, K., … Ferguson, N. (2020). Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet Infectious Diseases, 20(6), 669-677. https://doi.org/10.1016/s1473-3099(20)30243-7. |
[66] | Wang, J., Jiang, M., Chen, X., & Montaner, L. J. (2020). Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. Journal Of Leukocyte Biology, 108(1), 17-41. |
[67] | Wang, K., Chen, W., Zhou, Y. S., Lian, J. Q., Zhang, Z., Du, P., Gong, L., Zhang, Y., Cui, H. Y., Geng, J. J., Wang, B., Sun, X., Wang, C., Yang, X., Lin, P., Deng, Y. Q., Wei, D., Yang, X. M., Zhu, Y. M., … Chen, Z. N. (2020). SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. BioRxiv. |
[68] | Weiss, S. R., & Leibowitz, J. L. (2011). Coronavirus Pathogenesis. Advances In Virus Research, 85-164. https://doi.org/10.1016/b978-0-12-385885-6.00009-2. |
[69] | Weiss, S. R., & Navas-Martin, S. (2005). Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiology and Molecular Biology Reviews, 69(4), 635-664. |
[70] | Wilson, J. G., Liu, K. D., Zhuo, H., Caballero, L., McMillan, M., Fang, X., Cosgrove, K., Vojnik, R., Calfee, C. S., Lee, J. W., Rogers, A. J., Levitt, J., Wiener-Kronish, J., Bajwa, E. K., Leavitt, A., McKenna, D., Thompson, B. T., & Matthay, M. A. (2015). Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. The Lancet Respiratory Medicine, 3(1), 24-32. |
[71] | Wong, G., Liu, W., Liu, Y., Zhou, B., Bi, Y., & Gao, G. F. (2015). MERS, SARS, and Ebola: the role of super-spreaders in infectious disease. Cell Host & Microbe, 18(4), 398-401. |
[72] | Wu, R., Wang, L., Kuo, H.-C. D., Shannar, A., Peter, R., Chou, P. J., Li, S., Hudlikar, R., Liu, X., Liu, Z., Poiani, G. J., Amorosa, L., Brunetti, L., & Kong, A. N. (2020). An update on current therapeutic drugs treating COVID-19. Current Pharmacology Reports, 1. |
[73] | Xiao, K., Hou, F., Huang, X., Li, B., Qian, Z. R., & Xie, L. (2020). Mesenchymal stem cells: current clinical progress in ARDS and COVID-19. Stem Cell Research & Therapy, 11(1), 1-7. |
[74] | Xiu, S., Dick, A., Ju, H., Mirzaie, S., Abdi, F., Cocklin, S., Zhan, P., & Liu, X. (2020). Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities. Journal of Medicinal Chemistry. |
[75] | Ye, Q., Wang, B., & Mao, J. (2020a). Cytokine storm in COVID-19 and treatment. Journal Of Infection. |
[76] | Ye, Q., Wang, B., & Mao, J. (2020b). The pathogenesis and treatment of the Cytokine Storm in COVID-19. Journal Of Infection, 80(6), 607-613. |
[77] | Yuen, K. S., Ye, Z. W., Fung, S. Y., Chan, C. P., & Jin, D. Y. (2020). SARS-CoV-2 and COVID-19: The most important research questions. Cell & Bioscience, 10(1), 1-5. |
[78] | Zaim, S., Chong, J. H., Sankaranarayanan, V., & Harky, A. (2020). COVID-19 and multi-organ response. Current Problems in Cardiology, 100618. |
[79] | Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46(4), 586-590. |
[80] | Zhang, H., Wang, L., Chen, Y., Wu, Q., Chen, G., Shen, X., Wang, Q., Yan, Y., Yu, Y., Zhong, Y., Wang, X., Chua, M., & Xie, C. (2020). Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China. Cancer, 126(17), 4023–4031. https://doi.org/10.1002/cncr.33042. |
[81] | Zhang, Y., Odiwuor, N., Xiong, J., Sun, L., Nyaruaba, R. O., Wei, H., & Tanner, N. A. (2020). Rapid molecular detection of SARS-CoV-2 (COVID-19) virus RNA using colorimetric LAMP. medRxiv. https://doi.org/10.1101/2020.02.26.20028373. |
[82] | Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., & Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727-733. https://doi.org/10.1056/nejmoa2001017. |
[83] | Zou, L., Dai, L., Zhang, X., Zhang, Z., & Zhang, Z. (2020). Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19. Archives of Pharmacal Research, 1-8. |